(Q27919347)

English

ERCC5 RS751402

genetic variant

rs751402

In more languages

Statements

5 Prime UTR Variant

1 reference

22 January 2022

https://civic.genome.wustl.edu/links/variants/255

single-nucleotide polymorphism

1 reference

22 January 2022

https://civic.genome.wustl.edu/links/variants/255

human chromosome 13

genomic assembly

Genome assembly GRCh37

1 reference

22 January 2022

https://civic.genome.wustl.edu/links/variants/255

103498198

genomic assembly

Genome assembly GRCh37

1 reference

22 January 2022

https://civic.genome.wustl.edu/links/variants/255

103498198

genomic assembly

Genome assembly GRCh37

1 reference

22 January 2022

https://civic.genome.wustl.edu/links/variants/255

biological variant of

1 reference

22 January 2022

https://civic.genome.wustl.edu/links/variants/255

negative prognostic predictor for

parietal lobe ependymoma

determination method

CIViC evidence level B

CIViC 3-star trust rating

1 reference

22 January 2022

https://civic.genome.wustl.edu/links/evidence/665

A common polymorphism in the 5' UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy

Identifiers

CIViC variant ID

1 reference

22 January 2022

https://civic.genome.wustl.edu/links/variants/255

dbSNP Reference SNP number

1 reference

HGVS nomenclature

NC_000013.10:g.103498198A>G

1 reference

22 January 2022

https://civic.genome.wustl.edu/links/variants/255

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27919347&oldid=2014797824"